Halozyme Therapeutics
HALO
#2321
Rank
C$11.28 B
Marketcap
C$95.15
Share price
0.49%
Change (1 day)
28.35%
Change (1 year)

Earnings for Halozyme Therapeutics (HALO)

Earnings in 2025 (TTM): C$0.65 Billion

According to Halozyme Therapeutics's latest financial reports the company's current earnings are C$1.39 Billion. a decrease over its 2024 earnings that were of C$0.76 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Halozyme Therapeutics from 2002 to 2025

Annual earnings

Year Earnings Change
2025 C$0.64 B-16.2%
2024 C$0.76 B59.94%
2023 C$0.47 B39.94%
2022 C$0.34 B0.16%
2021 C$0.34 B92.2%
2020 C$0.17 B-278.96%
2019 -C$99.54 Million-9.45%
2018 -C$0.11 Billion-229.51%
2017 C$84.87 M-160.48%
2016 -C$0.15 Billion216.03%
2015 -C$44.41 Million-52.86%
2014 -C$94.2 Million-18.09%
2013 -C$0.12 Billion55.88%
2012 -C$73.78 Million169.94%
2011 -C$27.34 Million-63.44%
2010 -C$74.75 Million-7.19%
2009 -C$80.54 Million15.91%
2008 -C$69.48 Million83.89%
2007 -C$37.79 Million78.1%
2006 -C$21.22 Million16%
2005 -C$18.29 Million45.24%
2004 -C$12.6 Million682.42%
2003 -C$1.61 Million1659.12%
2002 -C$0.1 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$35.78 B 5,464.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$14.59 B 2,168.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$42.87 B 6,566.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$10.55 B 1,540.37%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
-C$0.7 Billion-208.81%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
C$1.93 M-99.70%๐Ÿ‡บ๐Ÿ‡ธ USA